Abemaciclib

Abemaciclib is a targeted medication used to treat certain types of breast cancer, particularly hormone receptor-positive forms that are advanced or metastatic. It works by inhibiting specific proteins called cyclin-dependent kinases (CDKs) that help cancer cells grow and divide. By blocking these proteins, abemaciclib helps slow down or stop the growth of the cancer. It is often used in combination with hormone therapies and is taken as a pill. While it can be effective, like all medications, it may come with side effects and is typically prescribed after careful evaluation by a healthcare professional.